NGOs petition for lopinavir plus ritonavir compulsory licence in Colombia

A number of NGOs are pushing for Colombian authorities to issue a compulsory licence for lopinavir plus ritonavir, Abbott's HIV/AIDS drug Kaletra, claiming that access to the antiretroviral is of public interest.

A number of NGOs are pushing for Colombian authorities to issue a compulsory licence for lopinavir plus ritonavir, Abbott's HIV/AIDS drug Kaletra, claiming that access to the antiretroviral is of public interest.

The Working Group of HIV/AIDS Organizations, the Colombian Network of People Living with HIV, Health Action International and The Foundation...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category